Chemicals and Materials North American crop protection chemicals market
North American Crop Protection Chemicals Market to be Worth
$27,806.4 Million by 2018
The North American Crop Protection Chemicals Market covers various types of
products being used in the farms to safeguard the crops, by controlling the population of
organisms considered harmful or those that can potentially damage or adversely affect the
growth of crops. Crop protection chemicals are mainly divided into herbicides, insecticides
and fungicides. Pesticides include both synthetic pesticides and bio-based pesticides, are
the largest market segment owing to their wide-spread use in bulk quantities. Adjuvants
are essentially pharmacological or immunological agents used to modify or enhance the
effect of other vaccines and drugs.
Request for sample PDF:
https://www.marketsandmarkets.com/pdfdownload.asp?id=1132
Insecticides are widely used because insects and parasites cause maximum damage to the
crops during cultivation. Insecticides are used in large volume and they show their action
for a longer period of time as compared to others. But excessive use of any pesticide results
in the development of chemical toxicity for humans, animals, and environment owing to
soil leaching and water contamination. Overall, it is essential to use crop protection
pesticides in appropriate quantity and time to minimize their adverse effects and to bring
to maximum benefits. The North and Latin American crop protection chemicals market, in
terms of active ingredient volume was estimated at 1,064.1 KT in 2011 and is expected to
reach 1,322.5 KT by 2018.
The North American crop protection chemicals market has been divided into patented and
generic pesticides. Almost over 67% of the market share belongs to patented or
proprietary active ingredients, while 33% of this market is generic. The proprietary
pesticides market has been built with a strong focus on North American crop protection
chemicals based on stringent regulations, driven by the U.S. and European standards. In
such situation, most of the major global players are focusing to slim down their production
capacity of low-revenue ($million) off-patent proprietary products.